NUWELLIS, INC. Lease, Cost
NUWELLIS, INC. (NUWE) reported Lease, Cost of $447.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-03-11
- NUWELLIS, INC. lease, cost for the quarter ending 2019-12-31 was $72.00K.
- NUWELLIS, INC. lease, cost for the quarter ending 2019-09-30 was $79.00K.
- NUWELLIS, INC. lease, cost for the quarter ending 2019-06-30 was $86.00K.
- NUWELLIS, INC. lease, cost for the quarter ending 2019-03-31 was $75.00K.
- NUWELLIS, INC. lease, cost for fiscal 2025 was $447.00K, a 13.16% increase from fiscal 2024.
- NUWELLIS, INC. lease, cost for fiscal 2024 was $395.00K, a 1.02% increase from fiscal 2023.
- NUWELLIS, INC. lease, cost for fiscal 2023 was $391.00K, a 7.12% increase from fiscal 2022.
- NUWELLIS, INC. lease, cost for fiscal 2022 was $365.00K, a 6.73% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $447.00K 10-K · filed 2026-03-11 | |||
| 2024-12-31 | $395.00K 10-K · filed 2026-03-11 | |||
| 2023-12-31 | $391.00K 10-K · filed 2025-03-11 | |||
| 2022-12-31 | $365.00K 10-K · filed 2024-03-11 | |||
| 2021-12-31 | $342.00K 10-K · filed 2023-03-03 | |||
| 2020-12-31 | $327.00K 10-K · filed 2022-03-03 | |||
| 2019-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $151.00K derived: sum of 2 quarters · filed 2021-03-25 | $237.00K derived: sum of 3 quarters · filed 2021-03-25 | $315.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $79.00K 10-Q · filed 2019-11-08 | $165.00K derived: sum of 2 quarters · filed 2019-11-08 | $243.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $86.00K 10-Q · filed 2019-08-08 | $161.00K 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $75.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |